Marlene Galizi
Gastroenterology · Hartsdale, NYNPI 1568436319
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 331 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 43.0% of the total. Reporting peaked in 2022 at $1,508 and has fallen 60.4% since, to $597 in 2023.
Across 331 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- AbbVie$699
- Takeda Pharmaceuticals U.S.A., Inc.$486
- Bristol Myers Squibb$389
- QOL Medical, LLC$255
- Ironwood Pharmaceuticals, Inc$218
- plus $1K from 13 others
What the payments were for
- Food & beverage$5,597100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 145 | $2,406 |
| AbbVie(2 entities) | 41 | $699 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $486 |
| Bristol Myers Squibb | 29 | $389 |
| QOL Medical, LLC | 14 | $255 |
| Ironwood Pharmaceuticals, Inc | 12 | $218 |
| Ardelyx, Inc. | 7 | $163 |
| Redhill Biopharma Inc. | 9 | $160 |
| Alfasigma USA, Inc. | 7 | $128 |
| Vivus LLC | 7 | $110 |
| Gilead | 6 | $108 |
| Intercept Pharmaceuticals, Inc. | 5 | $101 |
| Braintree Laboratories, Inc. | 5 | $98 |
| Johnson & Johnson | 4 | $69 |
| Concordia Pharmaceuticals Inc. | 4 | $68 |
| Nestle Healthcare Nutrition Inc. | 3 | $57 |
| Pfizer | 2 | $46 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
How this compares
$5,597 in reported general payments places this provider in the 70th percentile of 1,682 gastroenterology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lansoprazole | 11 | $364 |
| Pantoprazole Sodium | 13 | $238 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Hartsdale
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Maya SrivastavaWilliamsville$1.8M
- Melissa PalmerPlainview$1M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.